Comparative Analysis of Immune Repertoires between Bactrian Camel's Conventional and Heavy-Chain Antibodies

Compared to classical antibodies, camel heavy chain antibodies (HCAbs) are smaller in size due to lack of the light chain and the first constant domain of the heavy chain (CH1 region). The variable regions of HCAbs (VHHs) are more soluble and stable than that of conventional antibodies (VHs). Even with such simple structure, they are still functional in antigen binding. Although HCAbs have been extensively investigated over the past two decades, most efforts have been based upon low throughput sequence analysis, and there are only limited reports trying to analyze and describe the complete immune repertoire (IR) of camel HCAbs. Here we leveraged the high-throughput data generated by Next Generation Sequencing (NGS) of the variable domains of the antibody heavy chains from three Bactrian camels to conduct in-depth comparative analyses of the immunoglobulin repertoire. These include analyses of the complementary determining region 3 (CDR3) length and distribution, mutation rate, antibody characteristic amino acids, the distribution of the cysteine (Cys) codons, and the non-classical VHHs. We found that there is higher diversity in the CDR2 than in the other sub-regions, and there is a higher mutation rate in the VHHs than in the VHs (P < 0.05). In addition to substitutions at amino acid (AA) residue positions NO.49/50/52 between VH and VHH clones, we also observed other substitutions at the positions NO.40/54/57/96/101 that could lead to additional structural alterations. We also found that VH-derived VHH clones, referred to as non-classical VHH clones in this study, accounted for about 8% of all clones. Further, only 5%-10% clones had the Trp > Arg AA substitution at the first position of framework 4 for all types of clones. We present, for the first time, a relatively complete picture of the Bactrian camel antibody immune repertoire, including conventional antibody (Ab) and HCAbs, using PCR and in silico analysis based on high-throughput NGS data.

[1]  Alastair D G Lawson,et al.  Analysis of heavy and light chain sequences of conventional camelid antibodies from Camelus dromedarius and Camelus bactrianus species. , 2014, Journal of immunological methods.

[2]  S. Muyldermans,et al.  Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. , 1994, Protein engineering.

[3]  Heinrich Leonhardt,et al.  Targeting and tracing antigens in live cells with fluorescent nanobodies , 2006, Nature Methods.

[4]  David Wu,et al.  Detection of Minimal Residual Disease in B Lymphoblastic Leukemia by High-Throughput Sequencing of IGH , 2014, Clinical Cancer Research.

[5]  S. Muyldermans,et al.  A general protocol for the generation of Nanobodies for structural biology , 2014, Nature Protocols.

[6]  J. Tanha,et al.  Prokaryotic expression of antibodies , 2005, Cancer and Metastasis Reviews.

[7]  George Georgiou,et al.  High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire , 2013, Nature Biotechnology.

[8]  A. Plückthun,et al.  Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. , 1988, Science.

[9]  A. Lesk,et al.  Elbow motion in the immunoglobulins involves a molecular ball-and-socket joint , 1988, Nature.

[10]  L. Wyns,et al.  Selection and identification of single domain antibody fragments from camel heavy‐chain antibodies , 1997, FEBS letters.

[11]  S. Muyldermans,et al.  A Novel Promiscuous Class of Camelid Single-Domain Antibody Contributes to the Antigen-Binding Repertoire , 2010, The Journal of Immunology.

[12]  L. Wyns,et al.  Camel heavy‐chain antibodies: diverse germline VHH and specific mechanisms enlarge the antigen‐binding repertoire , 2000, The EMBO journal.

[13]  R. White,et al.  High-Throughput Sequencing of the Zebrafish Antibody Repertoire , 2009, Science.

[14]  A. Plückthun,et al.  High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. , 1999, Cancer research.

[15]  Meng Zhang,et al.  Comprehensive analysis of the T-cell receptor beta chain gene in rhesus monkey by high throughput sequencing , 2015, Scientific Reports.

[16]  Xun Xu,et al.  IMonitor: A Robust Pipeline for TCR and BCR Repertoire Analysis , 2015, Genetics.

[17]  L. Riechmann,et al.  ‘Camelising’ human antibody fragments: NMR studies on VH domains , 1994, FEBS letters.

[18]  J. Frère,et al.  β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae , 2001, Antimicrobial Agents and Chemotherapy.

[19]  Jurgen Del-Favero,et al.  Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform , 2015, mAbs.

[20]  D. Campana,et al.  Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia. , 2012, Blood.

[21]  L. Wyns,et al.  Single‐domain antibody fragments with high conformational stability , 2002, Protein science : a publication of the Protein Society.

[22]  L. Wyns,et al.  Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH. , 2005, Journal of molecular biology.

[23]  L. Wyns,et al.  Camelid immunoglobulins and nanobody technology. , 2009, Veterinary immunology and immunopathology.

[24]  Mikhail Shugay,et al.  Towards error-free profiling of immune repertoires , 2014, Nature Methods.

[25]  Seung Hyun Kang,et al.  Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells , 2010, Nature Biotechnology.

[26]  David Fenyö,et al.  A robust pipeline for rapid production of versatile nanobody repertoires , 2014, Nature Methods.

[27]  S. Muyldermans,et al.  The specific variable domain of camel heavy-chain antibodies is encoded in the germline. , 1998, Journal of molecular biology.

[28]  Siu-Ming Yiu,et al.  COPE: an accurate k-mer-based pair-end reads connection tool to facilitate genome assembly , 2012, Bioinform..

[29]  K. D. Hardman,et al.  Single-chain antigen-binding proteins. , 1988, Science.

[30]  H. Leonhardt,et al.  Engineering antibodies and proteins for molecular in vivo imaging. , 2011, Current opinion in biotechnology.

[31]  Serge Muyldermans,et al.  Nanobodies: natural single-domain antibodies. , 2013, Annual review of biochemistry.

[32]  H. de Haard,et al.  Properties, production, and applications of camelid single-domain antibody fragments , 2007, Applied Microbiology and Biotechnology.